Results 111 to 120 of about 9,605 (202)

Advances in Biosimilars: A Systematic Review of Machine Learning Applications. [PDF]

Pharmaceuticals (Basel)
Duarte V, Bas TG.
europepmc   +1 more source

Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro. [PDF]

PLoS One
Gootjes C, Zwaginga JJ, Nikolic T, Roep BO.   +3 more
europepmc   +1 more source

Budget impact analysis of the introduction of ranibizumab's biosimilar to the Jordanian joint procurement system. [PDF]

Front Public Health
Hamida JA, Alkhatib NS, Hammour KA, Halloush S, Kurdi A, Balkhi B, Alfayez OM, Mousa R.   +7 more
europepmc   +1 more source

Biosimilars [PDF]

Zeitschrift für Rheumatologie, 2015
G.-R. Burmester, U. Müller-Ladner
openaire   +1 more source

Posterior segment inflammation with venous involvement following a switch to a ranibizumab biosimilar (Ximluci®): a case report. [PDF]

Am J Ophthalmol Case Rep
Conte S, Nassisi M, Mainetti C, Seregni L, Viola F.   +4 more
europepmc   +1 more source

Patient out-of-pocket costs and rheumatology biosimilar competition. [PDF]

J Manag Care Spec Pharm
Dayer VW, Hansen RN, Roth J, Jofre-Bonet M, Sullivan SD.   +4 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Biosimilar anti-vascular endothelial growth factor agents: Clinical outcomes, safety, and cost-effectiveness in India. [PDF]

Indian J Ophthalmol
Chakraborty D, Sinha TK, Boral S, Das A.
europepmc   +1 more source

Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study). [PDF]

Pharmaceuticals (Basel)
Chakraborty D, Sinha TK, Sinha S, Biswas RK, Das A, Maiti A, Bhattacharya R, Dan S, Rungta D, Das S.   +9 more
europepmc   +1 more source

Observational study of trastuzumab biosimilar in patients with HER2-positive breast cancer under routine clinical practice conditions in Morocco. [PDF]

BMC Cancer
Errihani H, Berrada N, El Bachiri M, Jouhadi H, Kabbaj O, Bourhafour M, Benider A, Khouchani M, Belbaraka G, Acharki A, Samlali R, Upveja KH.   +11 more
europepmc   +1 more source